NCT06609174 - AI-SCREENDCM Decentralized Clinical Trial - Pilot Study | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Cardiomyopathy

Interventions

DIAGNOSTIC_TEST

KardiaRx ECG Screening and AI interpretation of ECG

The Kardia 6-lead device is an ambulatory, wireless device that connects to a smartphone. The KardiaRx App processes the signal acquired from the Kardia device into a real-time ECG. ECG will be interpreted by an AI algorithm

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester